Long-term dienogest treatment in endometriosis: Consensus from Taiwanese experts

Jah-Yao Liu, Bor-Ching Sheu, Bor‐Ching Sheu, Cherry Yin-Yi Chang, Chih-Feng Yen, Chih‐Feng Yen, Meng-Hsing Wu, Yi-Jen Chen, Tsung-Hsuan Lai, Kuo‐Chung Lan, Kuo-Chung Lan, Ya-Min Cheng, Yung-Chieh Tsai, Kim Seng Law, Kim-Seng Law, Wen‐Yih Wu, Wen-Yih Wu, San-Nung Chen, San‐Nung Chen
Taiwanese journal of obstetrics & gynecology · 2024 · vol. 63(6) , pp. 823–825 · doi:10.1016/j.tjog.2024.07.015 · PMID:39481987 · W4403922182
editorial OA: diamond CC0 ⤵ 2 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

Taiwanese experts developed recommendations for long-term dienogest treatment in endometriosis, advising individualized strategies, symptom control, recurrence reduction, and monitoring with ultrasounds, blood tests, and breast screening.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Dienogest has been proven effective as long-term therapeutic option for pelvic pain caused by endometriosis. However, in Taiwan, there is a lack of a well-tailored consensus on its long-term administration. To address this gap, Taiwanese experts in collaboration with the Taiwan Endometriosis Society (TES), convened to provide structured recommendations on dienogest treatment and monitoring strategies. Drawing from clinical evidence and collective expertise, the experts formulated individualized treatment strategies based on treatment objectives and the patient's demographics. The experts recommend long-term dienogest administration for endometriosis patients for appropriate symptom control while reducing the risk of disease recurrence. Specifically, they recommend regular ultrasound examinations and relevant blood tests to monitor disease progression and therapeutic response with additional breast screening for patients at high risk for breast cancer. These recommendations aim to provide physicians with comprehensive guidance on the long-term administration of dienogest for endometriosis, ensuring patient safety and optimizing treatment outcomes.

My notes (saved in your browser only)

Condition tags

mesh:D004715mesh:D017699endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Nandrolone Nandrolone Nandrolone Nandrolone Nandrolone Nandrolone Nandrolone Nandrolone Nandrolone Nandrolone Nandrolone

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (13)

Cited by (2)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-18T00:32:06.137176+00:00
License: CC0 · commercial use OK